TUGAS STUDI KASUS FARMAKOTERAPI II

- Membuat MAKALAH ( meliputi etiologi, patofisiologi, tata laksana terapi, pembahasan kasus,
pembahasan pertanyaan kasus, dapus ) dan PPT dari STUDI KASUS BU AFIFAH DAN BU EMA
- Satu kelas dibagi menjadi 2 kelompok besar :
Kelompok 1 7 mengerjakan studi kasus Bu Afifah ; Kelompok 7 8 mengerjakan studi
kasus Bu Ema
- Dikumpulkan KAMIS, 30 MARET 2017 untuk Studi Kasus Bu Afifah
- Untuk kelompok 7-8 menunggu studi kasus dari Bu Ema yaaaa .

KELOMPOK 1 KELOMPOK 4 KELOMPOK 7

1. 13-37 1. 14-05 1. 14-10 KELOMPOK 11

2. 13-104 2. 14-37 2. 14-78
1. 14-18
3. 14-28 3. 14-64 3. 14-98
2. 14-47
4. 14-58 4. 14-92 4. 14-102
3. 14-50
5. 14-87 5. 14-117 5. 14-114
4. 14-75
KELOMPOK 2 KELOMPOK 5 KELOMPOK 8 5. 14-112

1. 14-02 1. 14-06 1. 14-14 KELOMPOK 12

2. 14-30 2. 14-38 2. 14-42
1. 14-20
3. 14-60 3. 14-66 3. 14-54
2. 14-48
4. 14-88 4. 14-94 4. 14-80
3. 14-76
5. 14-115 5. 14-118 5. 14-108
4. 14-113
KELOMPOK 3 KELOMPOK 6 KELOMPOK 9
KELOMPOK 13
1. 14-04 1. 14-08 1. 14-15
1. 14-22
2. 14-36 2. 14-40 2. 14-44
2. 14-52
3. 14-62 3. 14-68 3. 14-56
3. 14-79
4. 14-89 4. 14-96 4. 14-84
4. 14-106
5. 14-116 5. 14-120 5. 14-109
KELOMPOK 14
KELOMPOK 10
1. 14-26
1. 14-16
2. 14-61
2. 14-46
3. 14-86
3. 14-70
4. 14-95
4. 14-85
5. 14-110
 Case Study Urinary Tract Infetion

Ny. V.Q a 20-year-old woman (married, no children) with no previous history of UTI, complains of
burning on urination, frequent urination of a small amount, and bladder pain. She has no fever or CVA
tenderness. A clean-catch midstream urine sample shows gram-negative rods on Gram stain. A culture
and sensitivity (C&S) test is ordered, and the results of a STAT UA are as follows: appearance, straw-
colored (normal, straw); specific gravity, 1.015 (normal, 1.0011.035); pH, 8.0 (normal, 4.57.5); and
protein, glucose, ketones, bilirubin, and blood are all negative (normal, all negative); WBC, 10 to 15
cells/mm3 (normal, 02 cells/mm3); red blood cells (RBC), 0 to 1 cells/mm3 (normal, 02 cells/mm3);
bacteria, many (normal, 0 to rare); epithelial cells, 3 to 5 cells/mm3 (normal, 0 to few cells/mm3). Based
on these findings, V.Q. is presumed to have a lower UTI.

1. What should be the goals of therapy and treatment plan at this time?
2. What therapy is appropriate for V.Q?
3. What treatment duration options are available for V.Q.?
4. Would a 3-day course of therapy or single-dose therapy be preferred for V.Q.?